KIT and gastrointestinal stromal tumor: Mutational analysis of 38 GIST patients at diagnosis (n = 19 affected by advanced GIST and n = 19 with localized disease) identified KIT/PDGFRA mutations in 33 patients (87%), while the remaining 5 resulted KIT/PDGFRA WT (13%).